Free and Glucuronide Whole Blood Cannabinoids' Pharmacokinetics after Controlled Smoked, Vaporized, and Oral Cannabis Administration in Frequent and Occasional Cannabis Users: Identification of Recent Cannabis Intake
Matthew N. Newmeyer(Johns Hopkins University), Marilyn A. Huestis(Smithsonian Institution), Karl B. Scheidweiler(National Institute on Drug Abuse), Allan J. Barnes(National Institutes of Health), Madeleine J. Swortwood(Sam Houston State University), Osama A. Abulseoud(Mayo Clinic in Arizona)
Cited by 178
Related Papers
Human Cannabinoid Pharmacokinetics
|Chemistry & Biodiversity|2007|1.1k
Synthetic cannabinoids: Epidemiology, pharmacodynamics, and clinical implications
|Drug and Alcohol Dependence|2014|697
Neuropsychological Performance in Long-term Cannabis Users
|Archives of General Psychiatry|2001|656
Cannabis Effects on Driving Skills
|Clinical Chemistry|2012|613
Matrix effect in bio-analysis of illicit drugs with LC-MS/MS: Influence of ionization type, sample preparation, and biofluid
|Journal of the American Society for Mass Spectrometry|2003|599